Founder & CEO, Australis Scientific
Nick Agahari
A new business model is emerging in MedTech: medical device manufacturers (MDMs) stepping into the role of care providers.
As shifts in clinical workflows, reimbursement policy, and patient expectations accelerate, some manufacturers are going beyond product delivery to build in-house clinical teams. These organizations are now billing insurers for professional services and partnering with ordering providers (rather than competing with them) to create new value streams and support better patient care.
Done right, this model enables MDMs to provide clinicians with access to devices and services uniquely tailored to their needs and the patient population they serve. It opens the door to tighter alignment between product performance and clinical outcomes. But it also demands a new operational playbook.
Manufacturers entering the provider space must address a range of challenges: ensuring clinical quality, navigating regulatory requirements not originally designed for them, integrating with fragmented EHR systems, and building sustainable provider partnerships.
Join Orthogonal and a panel of innovators leading this transformation for a candid and tactical session. You’ll learn how early adopters are building hybrid device-care businesses and what it takes to do it well.
Don’t miss this opportunity to learn from those already forging a path in this complex but promising space.
Founder & CEO, Australis Scientific
Nick Agahari
CEO, CorVista Health
Adrian Lam
CEO and Founder, Orthogonal
Bernhard Kappe
Chief Solutions Officer, Orthogonal
Randy Horton
Related Posts
Talk
Leveraging Automation to Deliver High-Quality MedTech Software
Talk
The Playbook for Running a Multi-Partner Engineering Organization
Talk
Bridging the Gap: SaMD Strategy for Teams Built on Hardware
Talk
FDA/CDRH Changes: How MedTech Companies Can Prepare Webinar Summary